 | • レポートコード：MRC2012B0242 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、CRISPR・Cas遺伝子の世界市場を広く調査・分析し、今後の市場展望をまとめております。CRISPR・Cas遺伝子の種類別市場規模（ベクターベースCas、DNAフリーCas、細胞株エンジニアリング）、用途別市場規模（バイオテクノロジー・製薬会社、学者・政府研究所、委託研究機関（CRO））、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：CRISPR Therapeutics、F. Hoffmann-La Roche Ltd.、Caribou Biosciences, Inc.、AstraZeneca、Egenesis、Addgene、Genscrip、Editas Medicine, Inc.、Cellectis、Horizon Discovery Group Plc、New England BioLabs、Mammoth Biosciences、Danaher Corporation、Cibus、Takara Bio, Inc.、Merck KGaA、Intellia Therapeutics, Inc.、Inscripta, Inc.、Synthego、Lonza ・地域別グローバル市場分析 2015年-2020年 ・CRISPR・Cas遺伝子の北米市場（アメリカ、カナダ、メキシコ） ・CRISPR・Cas遺伝子のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・CRISPR・Cas遺伝子のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・CRISPR・Cas遺伝子の南米市場（ブラジル、アルゼンチン） ・CRISPR・Cas遺伝子の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ベクターベースCas、DNAフリーCas、細胞株エンジニアリング ・用途別分析：バイオテクノロジー・製薬会社、学者・政府研究所、委託研究機関（CRO） ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The CRISPR & Cas Genes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global CRISPR & Cas Genes market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
CRISPR & Cas Genes market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, CRISPR & Cas Genes market has been segmented into:
Vector-based Cas
DNA-free Cas
Cell Line Engineering
By Application, CRISPR & Cas Genes has been segmented into:
Biotechnology and Pharmaceutical Companies
Academics and Government Research Institutes
Contract Research Organizations (CROs)
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global CRISPR & Cas Genes market presented in the report. This section sheds light on the sales growth of different regional and country-level CRISPR & Cas Genes markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global CRISPR & Cas Genes market.
The report offers in-depth assessment of the growth and other aspects of the CRISPR & Cas Genes market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and CRISPR & Cas Genes Market Share Analysis
CRISPR & Cas Genes competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, CRISPR & Cas Genes sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the CRISPR & Cas Genes sales, revenue and market share for each player covered in this report.
The major players covered in CRISPR & Cas Genes are:
CRISPR Therapeutics
F. Hoffmann-La Roche Ltd.
Caribou Biosciences, Inc.
AstraZeneca
Egenesis
Addgene
Genscrip
Editas Medicine, Inc.
Cellectis
Horizon Discovery Group Plc
New England BioLabs
Mammoth Biosciences
Danaher Corporation
Cibus
Takara Bio, Inc.
Merck KGaA
Intellia Therapeutics, Inc.
Inscripta, Inc.
Synthego
Lonza
Among other players domestic and global, CRISPR & Cas Genes market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 CRISPR & Cas Genes Market Overview
1.1 Product Overview and Scope of CRISPR & Cas Genes
1.2 Classification of CRISPR & Cas Genes by Type
1.2.1 Global CRISPR & Cas Genes Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global CRISPR & Cas Genes Revenue Market Share by Type in 2019
1.2.3 Vector-based Cas
1.2.4 DNA-free Cas
1.2.5 Cell Line Engineering
1.3 Global CRISPR & Cas Genes Market by Application
1.3.1 Overview: Global CRISPR & Cas Genes Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Academics and Government Research Institutes
1.3.4 Contract Research Organizations (CROs)
1.4 Global CRISPR & Cas Genes Market by Regions
1.4.1 Global CRISPR & Cas Genes Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of CRISPR & Cas Genes (2015-2025)
1.4.3 North America (USA, Canada and Mexico) CRISPR & Cas Genes Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) CRISPR & Cas Genes Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) CRISPR & Cas Genes Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) CRISPR & Cas Genes Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) CRISPR & Cas Genes Status and Prospect (2015-2025)
2 Company Profiles
2.1 CRISPR Therapeutics
2.1.1 CRISPR Therapeutics Details
2.1.2 CRISPR Therapeutics Major Business
2.1.3 CRISPR Therapeutics SWOT Analysis
2.1.4 CRISPR Therapeutics Product and Services
2.1.5 CRISPR Therapeutics CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2018-2019)
2.2 F. Hoffmann-La Roche Ltd.
2.2.1 F. Hoffmann-La Roche Ltd. Details
2.2.2 F. Hoffmann-La Roche Ltd. Major Business
2.2.3 F. Hoffmann-La Roche Ltd. SWOT Analysis
2.2.4 F. Hoffmann-La Roche Ltd. Product and Services
2.2.5 F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2018-2019)
2.3 Caribou Biosciences, Inc.
2.3.1 Caribou Biosciences, Inc. Details
2.3.2 Caribou Biosciences, Inc. Major Business
2.3.3 Caribou Biosciences, Inc. SWOT Analysis
2.3.4 Caribou Biosciences, Inc. Product and Services
2.3.5 Caribou Biosciences, Inc. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2018-2019)
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business
2.4.3 AstraZeneca SWOT Analysis
2.4.4 AstraZeneca Product and Services
2.4.5 AstraZeneca CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2018-2019)
2.5 Egenesis
2.5.1 Egenesis Details
2.5.2 Egenesis Major Business
2.5.3 Egenesis SWOT Analysis
2.5.4 Egenesis Product and Services
2.5.5 Egenesis CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2018-2019)
2.6 Addgene
2.6.1 Addgene Details
2.6.2 Addgene Major Business
2.6.3 Addgene Product and Services
2.6.4 Addgene CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2018-2019)
2.7 Genscrip
2.7.1 Genscrip Details
2.7.2 Genscrip Major Business
2.7.3 Genscrip Product and Services
2.7.4 Genscrip CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2018-2019)
2.8 Editas Medicine, Inc.
2.8.1 Editas Medicine, Inc. Details
2.8.2 Editas Medicine, Inc. Major Business
2.8.3 Editas Medicine, Inc. Product and Services
2.8.4 Editas Medicine, Inc. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2018-2019)
2.9 Cellectis
2.9.1 Cellectis Details
2.9.2 Cellectis Major Business
2.9.3 Cellectis Product and Services
2.9.4 Cellectis CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2018-2019)
2.10 Horizon Discovery Group Plc
2.10.1 Horizon Discovery Group Plc Details
2.10.2 Horizon Discovery Group Plc Major Business
2.10.3 Horizon Discovery Group Plc Product and Services
2.10.4 Horizon Discovery Group Plc CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2018-2019)
2.11 New England BioLabs
2.11.1 New England BioLabs Details
2.11.2 New England BioLabs Major Business
2.11.3 New England BioLabs Product and Services
2.11.4 New England BioLabs CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2018-2019)
2.12 Mammoth Biosciences
2.12.1 Mammoth Biosciences Details
2.12.2 Mammoth Biosciences Major Business
2.12.3 Mammoth Biosciences Product and Services
2.12.4 Mammoth Biosciences CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2018-2019)
2.13 Danaher Corporation
2.13.1 Danaher Corporation Details
2.13.2 Danaher Corporation Major Business
2.13.3 Danaher Corporation Product and Services
2.13.4 Danaher Corporation CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2018-2019)
2.14 Cibus
2.14.1 Cibus Details
2.14.2 Cibus Major Business
2.14.3 Cibus Product and Services
2.14.4 Cibus CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2018-2019)
2.15 Takara Bio, Inc.
2.15.1 Takara Bio, Inc. Details
2.15.2 Takara Bio, Inc. Major Business
2.15.3 Takara Bio, Inc. Product and Services
2.15.4 Takara Bio, Inc. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2018-2019)
2.16 Merck KGaA
2.16.1 Merck KGaA Details
2.16.2 Merck KGaA Major Business
2.16.3 Merck KGaA Product and Services
2.16.4 Merck KGaA CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2018-2019)
2.17 Intellia Therapeutics, Inc.
2.17.1 Intellia Therapeutics, Inc. Details
2.17.2 Intellia Therapeutics, Inc. Major Business
2.17.3 Intellia Therapeutics, Inc. Product and Services
2.17.4 Intellia Therapeutics, Inc. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2018-2019)
2.18 Inscripta, Inc.
2.18.1 Inscripta, Inc. Details
2.18.2 Inscripta, Inc. Major Business
2.18.3 Inscripta, Inc. Product and Services
2.18.3 Inscripta, Inc. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2018-2019)
2.19 Synthego
2.19.1 Synthego Details
2.19.2 Synthego Major Business
2.19.3 Synthego Product and Services
2.19.4 Synthego CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2018-2019)
2.20 Lonza
2.20.1 Lonza Details
2.20.2 Lonza Major Business
2.20.3 Lonza Product and Services
2.20.4 Lonza CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global CRISPR & Cas Genes Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 CRISPR & Cas Genes Players Market Share
3.2.2 Top 10 CRISPR & Cas Genes Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global CRISPR & Cas Genes Revenue and Market Share by Regions
4.2 North America CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
4.3 Europe CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
4.5 South America CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
5 North America CRISPR & Cas Genes Revenue by Countries
5.1 North America CRISPR & Cas Genes Revenue by Countries (2015-2020)
5.2 USA CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
5.3 Canada CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
5.4 Mexico CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
6 Europe CRISPR & Cas Genes Revenue by Countries
6.1 Europe CRISPR & Cas Genes Revenue by Countries (2015-2020)
6.2 Germany CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
6.3 UK CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
6.4 France CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
6.5 Russia CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
6.6 Italy CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
7 Asia-Pacific CRISPR & Cas Genes Revenue by Countries
7.1 Asia-Pacific CRISPR & Cas Genes Revenue by Countries (2015-2020)
7.2 China CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
7.3 Japan CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
7.4 Korea CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
7.5 India CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
8 South America CRISPR & Cas Genes Revenue by Countries
8.1 South America CRISPR & Cas Genes Revenue by Countries (2015-2020)
8.2 Brazil CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
8.3 Argentina CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue CRISPR & Cas Genes by Countries
9.1 Middle East & Africa CRISPR & Cas Genes Revenue by Countries (2015-2020)
9.2 Saudi Arabia CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
9.3 UAE CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
9.4 Egypt CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
9.5 South Africa CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global CRISPR & Cas Genes Revenue and Market Share by Type (2015-2020)
10.2 Global CRISPR & Cas Genes Market Forecast by Type (2019-2024)
10.3 Vector-based Cas Revenue Growth Rate (2015-2025)
10.4 DNA-free Cas Revenue Growth Rate (2015-2025)
10.5 Cell Line Engineering Revenue Growth Rate (2015-2025)
11 Global CRISPR & Cas Genes Market Segment by Application
11.1 Global CRISPR & Cas Genes Revenue Market Share by Application (2015-2020)
11.2 CRISPR & Cas Genes Market Forecast by Application (2019-2024)
11.3 Biotechnology and Pharmaceutical Companies Revenue Growth (2015-2020)
11.4 Academics and Government Research Institutes Revenue Growth (2015-2020)
11.5 Contract Research Organizations (CROs) Revenue Growth (2015-2020)
12 Global CRISPR & Cas Genes Market Size Forecast (2021-2025)
12.1 Global CRISPR & Cas Genes Market Size Forecast (2021-2025)
12.2 Global CRISPR & Cas Genes Market Forecast by Regions (2021-2025)
12.3 North America CRISPR & Cas Genes Revenue Market Forecast (2021-2025)
12.4 Europe CRISPR & Cas Genes Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific CRISPR & Cas Genes Revenue Market Forecast (2021-2025)
12.6 South America CRISPR & Cas Genes Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa CRISPR & Cas Genes Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global CRISPR & Cas Genes Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of CRISPR & Cas Genes by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global CRISPR & Cas Genes Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market CRISPR & Cas Genes Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global CRISPR & Cas Genes Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. CRISPR Therapeutics Corporate Information, Location and Competitors
Table 7. CRISPR Therapeutics CRISPR & Cas Genes Major Business
Table 8. CRISPR Therapeutics CRISPR & Cas Genes Total Revenue (USD Million) (2017-2018)
Table 9. CRISPR Therapeutics SWOT Analysis
Table 10. CRISPR Therapeutics CRISPR & Cas Genes Product and Solutions
Table 11. CRISPR Therapeutics CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. F. Hoffmann-La Roche Ltd. Corporate Information, Location and Competitors
Table 13. F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Major Business
Table 14. F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Total Revenue (USD Million) (2018-2019)
Table 15. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 16. F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Product and Solutions
Table 17. F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Caribou Biosciences, Inc. Corporate Information, Location and Competitors
Table 19. Caribou Biosciences, Inc. CRISPR & Cas Genes Major Business
Table 20. Caribou Biosciences, Inc. CRISPR & Cas Genes Total Revenue (USD Million) (2017-2018)
Table 21. Caribou Biosciences, Inc. SWOT Analysis
Table 22. Caribou Biosciences, Inc. CRISPR & Cas Genes Product and Solutions
Table 23. Caribou Biosciences, Inc. CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. AstraZeneca Corporate Information, Location and Competitors
Table 25. AstraZeneca CRISPR & Cas Genes Major Business
Table 26. AstraZeneca CRISPR & Cas Genes Total Revenue (USD Million) (2017-2018)
Table 27. AstraZeneca SWOT Analysis
Table 28. AstraZeneca CRISPR & Cas Genes Product and Solutions
Table 29. AstraZeneca CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Egenesis Corporate Information, Location and Competitors
Table 31. Egenesis CRISPR & Cas Genes Major Business
Table 32. Egenesis CRISPR & Cas Genes Total Revenue (USD Million) (2017-2018)
Table 33. Egenesis SWOT Analysis
Table 34. Egenesis CRISPR & Cas Genes Product and Solutions
Table 35. Egenesis CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Addgene Corporate Information, Location and Competitors
Table 37. Addgene CRISPR & Cas Genes Major Business
Table 38. Addgene CRISPR & Cas Genes Total Revenue (USD Million) (2017-2018)
Table 39. Addgene SWOT Analysis
Table 40. Addgene CRISPR & Cas Genes Product and Solutions
Table 41. Addgene CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Genscrip Corporate Information, Location and Competitors
Table 43. Genscrip CRISPR & Cas Genes Major Business
Table 44. Genscrip CRISPR & Cas Genes Total Revenue (USD Million) (2017-2018)
Table 45. Genscrip SWOT Analysis
Table 46. Genscrip CRISPR & Cas Genes Product and Solutions
Table 47. Genscrip CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Editas Medicine, Inc. Corporate Information, Location and Competitors
Table 49. Editas Medicine, Inc. CRISPR & Cas Genes Major Business
Table 50. Editas Medicine, Inc. CRISPR & Cas Genes Total Revenue (USD Million) (2017-2018)
Table 51. Editas Medicine, Inc. SWOT Analysis
Table 52. Editas Medicine, Inc. CRISPR & Cas Genes Product and Solutions
Table 53. Editas Medicine, Inc. CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Cellectis Corporate Information, Location and Competitors
Table 55. Cellectis CRISPR & Cas Genes Major Business
Table 56. Cellectis CRISPR & Cas Genes Total Revenue (USD Million) (2017-2018)
Table 57. Cellectis SWOT Analysis
Table 58. Cellectis CRISPR & Cas Genes Product and Solutions
Table 59. Cellectis CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Horizon Discovery Group Plc Corporate Information, Location and Competitors
Table 61. Horizon Discovery Group Plc CRISPR & Cas Genes Major Business
Table 62. Horizon Discovery Group Plc CRISPR & Cas Genes Total Revenue (USD Million) (2017-2018)
Table 63. Horizon Discovery Group Plc SWOT Analysis
Table 64. Horizon Discovery Group Plc CRISPR & Cas Genes Product and Solutions
Table 65. Horizon Discovery Group Plc CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. New England BioLabs Corporate Information, Location and Competitors
Table 67. New England BioLabs CRISPR & Cas Genes Major Business
Table 68. New England BioLabs CRISPR & Cas Genes Total Revenue (USD Million) (2017-2018)
Table 69. New England BioLabs SWOT Analysis
Table 70. New England BioLabs CRISPR & Cas Genes Product and Solutions
Table 71. New England BioLabs CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Mammoth Biosciences Corporate Information, Location and Competitors
Table 73. Mammoth Biosciences CRISPR & Cas Genes Major Business
Table 74. Mammoth Biosciences CRISPR & Cas Genes Total Revenue (USD Million) (2017-2018)
Table 75. Mammoth Biosciences SWOT Analysis
Table 76. Mammoth Biosciences CRISPR & Cas Genes Product and Solutions
Table 77. Mammoth Biosciences CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Danaher Corporation Corporate Information, Location and Competitors
Table 79. Danaher Corporation CRISPR & Cas Genes Major Business
Table 80. Danaher Corporation CRISPR & Cas Genes Total Revenue (USD Million) (2017-2018)
Table 81. Danaher Corporation SWOT Analysis
Table 82. Danaher Corporation CRISPR & Cas Genes Product and Solutions
Table 83. Danaher Corporation CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Cibus Corporate Information, Location and Competitors
Table 85. Cibus CRISPR & Cas Genes Major Business
Table 86. Cibus CRISPR & Cas Genes Total Revenue (USD Million) (2017-2018)
Table 87. Cibus SWOT Analysis
Table 88. Cibus CRISPR & Cas Genes Product and Solutions
Table 89. Cibus CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Takara Bio, Inc. Corporate Information, Location and Competitors
Table 91. Takara Bio, Inc. CRISPR & Cas Genes Major Business
Table 92. Takara Bio, Inc. CRISPR & Cas Genes Total Revenue (USD Million) (2017-2018)
Table 93. Takara Bio, Inc. SWOT Analysis
Table 94. Takara Bio, Inc. CRISPR & Cas Genes Product and Solutions
Table 95. Takara Bio, Inc. CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Merck KGaA Corporate Information, Location and Competitors
Table 97. Merck KGaA CRISPR & Cas Genes Major Business
Table 98. Merck KGaA CRISPR & Cas Genes Total Revenue (USD Million) (2017-2018)
Table 99. Merck KGaA SWOT Analysis
Table 100. Merck KGaA CRISPR & Cas Genes Product and Solutions
Table 101. Merck KGaA CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Intellia Therapeutics, Inc. Corporate Information, Location and Competitors
Table 103. Intellia Therapeutics, Inc. CRISPR & Cas Genes Major Business
Table 104. Intellia Therapeutics, Inc. CRISPR & Cas Genes Total Revenue (USD Million) (2017-2018)
Table 105. Intellia Therapeutics, Inc. SWOT Analysis
Table 106. Intellia Therapeutics, Inc. CRISPR & Cas Genes Product and Solutions
Table 107. Intellia Therapeutics, Inc. CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Inscripta, Inc. CRISPR & Cas Genes Type and Application
Table 109. Inscripta, Inc. CRISPR & Cas Genes Major Business
Table 110. Inscripta, Inc. CRISPR & Cas Genes Total Revenue (USD Million) (2017-2018)
Table 111. Inscripta, Inc. SWOT Analysis
Table 112. Inscripta, Inc. CRISPR & Cas Genes Product and Solutions
Table 113. Inscripta, Inc. CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. Synthego Corporate Information, Location and Competitors
Table 115. Synthego CRISPR & Cas Genes Major Business
Table 116. Synthego CRISPR & Cas Genes Total Revenue (USD Million) (2017-2018)
Table 117. Synthego SWOT Analysis
Table 118. Synthego CRISPR & Cas Genes Product and Solutions
Table 119. Synthego CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 120. Lonza Corporate Information, Location and Competitors
Table 121. Lonza CRISPR & Cas Genes Major Business
Table 122. Lonza CRISPR & Cas Genes Total Revenue (USD Million) (2017-2018)
Table 123. Lonza SWOT Analysis
Table 124. Lonza CRISPR & Cas Genes Product and Solutions
Table 125. Lonza CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 126. Global CRISPR & Cas Genes Revenue (Million USD) by Players (2015-2020)
Table 127. Global CRISPR & Cas Genes Revenue Share by Players (2015-2020)
Table 128. Global CRISPR & Cas Genes Revenue (Million USD) by Regions (2015-2020)
Table 129. Global CRISPR & Cas Genes Revenue Market Share by Regions (2015-2020)
Table 130. North America CRISPR & Cas Genes Revenue by Countries (2015-2020)
Table 131. North America CRISPR & Cas Genes Revenue Market Share by Countries (2015-2020)
Table 132. Europe CRISPR & Cas Genes Revenue (Million USD) by Countries (2015-2020)
Table 133. Asia-Pacific CRISPR & Cas Genes Revenue (Million USD) by Countries (2015-2020)
Table 134. South America CRISPR & Cas Genes Revenue by Countries (2015-2020)
Table 135. South America CRISPR & Cas Genes Revenue Market Share by Countries (2015-2020)
Table 136. Middle East and Africa CRISPR & Cas Genes Revenue (Million USD) by Countries (2015-2020)
Table 137. Middle East and Africa CRISPR & Cas Genes Revenue Market Share by Countries (2015-2020)
Table 138. Global CRISPR & Cas Genes Revenue (Million USD) by Type (2015-2020)
Table 139. Global CRISPR & Cas Genes Revenue Share by Type (2015-2020)
Table 140. Global CRISPR & Cas Genes Revenue Forecast by Type (2021-2025)
Table 141. Global CRISPR & Cas Genes Revenue by Application (2015-2020)
Table 142. Global CRISPR & Cas Genes Revenue Share by Application (2015-2020)
Table 143. Global CRISPR & Cas Genes Revenue Forecast by Application (2021-2025)
Table 144. Global CRISPR & Cas Genes Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. CRISPR & Cas Genes Picture
Figure 2. Global CRISPR & Cas Genes Revenue Market Share by Type in 2019
Figure 3. Vector-based Cas Picture
Figure 4. DNA-free Cas Picture
Figure 5. Cell Line Engineering Picture
Figure 6. CRISPR & Cas Genes Revenue Market Share by Application in 2019
Figure 7. Biotechnology and Pharmaceutical Companies Picture
Figure 8. Academics and Government Research Institutes Picture
Figure 9. Contract Research Organizations (CROs) Picture
Figure 10. Global CRISPR & Cas Genes Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America CRISPR & Cas Genes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe CRISPR & Cas Genes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific CRISPR & Cas Genes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America CRISPR & Cas Genes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa CRISPR & Cas Genes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global CRISPR & Cas Genes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global CRISPR & Cas Genes Revenue Share by Players in 2019
Figure 18. Global Top 5 Players CRISPR & Cas Genes Revenue Market Share in 2019
Figure 19. Global Top 10 Players CRISPR & Cas Genes Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global CRISPR & Cas Genes Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global CRISPR & Cas Genes Revenue Market Share by Regions (2015-2020)
Figure 23. Global CRISPR & Cas Genes Revenue Market Share by Regions in 2018
Figure 24. North America CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 25. Europe CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 27. South America CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 29. North America CRISPR & Cas Genes Revenue Market Share by Countries (2015-2020)
Figure 30. North America CRISPR & Cas Genes Revenue Market Share by Countries in 2019
Figure 31. USA CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 32. Canada CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 33. Mexico CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 34. Europe CRISPR & Cas Genes Revenue Market Share by Countries (2015-2020)
Figure 35. Europe CRISPR & Cas Genes Revenue Market Share by Countries in 2019
Figure 36. Germany CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 37. UK CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 38. France CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 39. Russia CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 40. Italy CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific CRISPR & Cas Genes Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific CRISPR & Cas Genes Revenue Market Share by Countries in 2019
Figure 43. China CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 44. Japan CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 45. Korea CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 46. India CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 48. South America CRISPR & Cas Genes Revenue Market Share by Countries (2015-2020)
Figure 49. South America CRISPR & Cas Genes Revenue Market Share by Countries in 2019
Figure 50. Brazil CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 51. Argentina CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa CRISPR & Cas Genes Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa CRISPR & Cas Genes Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 55. UAE CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 56. Egypt CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 57. South Africa CRISPR & Cas Genes Revenue and Growth Rate (2015-2020)
Figure 58. Global CRISPR & Cas Genes Revenue Share by Type (2015-2020)
Figure 59. Global CRISPR & Cas Genes Revenue Share by Type in 2019
Figure 60. Global CRISPR & Cas Genes Market Share Forecast by Type (2021-2025)
Figure 61. Global Vector-based Cas Revenue Growth Rate (2015-2020)
Figure 62. Global DNA-free Cas Revenue Growth Rate (2015-2020)
Figure 63. Global Cell Line Engineering Revenue Growth Rate (2015-2020)
Figure 64. Global CRISPR & Cas Genes Revenue Share by Application (2015-2020)
Figure 65. Global CRISPR & Cas Genes Revenue Share by Application in 2019
Figure 66. Global CRISPR & Cas Genes Market Share Forecast by Application (2021-2025)
Figure 67. Global Biotechnology and Pharmaceutical Companies Revenue Growth Rate (2015-2020)
Figure 68. Global Academics and Government Research Institutes Revenue Growth Rate (2015-2020)
Figure 69. Global Contract Research Organizations (CROs) Revenue Growth Rate (2015-2020)
Figure 70. Global CRISPR & Cas Genes Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global CRISPR & Cas Genes Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global CRISPR & Cas Genes Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America CRISPR & Cas Genes Revenue Market Forecast (2021-2025)
Figure 74. Europe CRISPR & Cas Genes Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific CRISPR & Cas Genes Revenue Market Forecast (2021-2025)
Figure 76. South America CRISPR & Cas Genes Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa CRISPR & Cas Genes Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
CRISPR・Cas遺伝子の世界市場（～2026年） CRISPR (clustered regularly interspaced short palindromic repeats) is a family of DNA sequences found in the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments of bacteriophages that had previously infected the prokaryote. They are used to d…- CRISPR・CRISPR関連（Cas）遺伝子の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The CRISPR And CRISPR-Associated (Cas) Genes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …
- ゲノム編集/ゲノム工学の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Genome Editing/Genome Engineering market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.9% in the forecast period of 2020 to 2025 and will expected to reach USD 4759.2 million by 2025, from USD 3386.9 million in 2019. The Ge…
- 遺伝子編集の世界市場（～2026年） Gemstones are elements of minerals which when polished and cut are used for making jewelry and other ornaments, as well as for decoration purposes. Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication th…
- 乳がん予測遺伝子検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Breast Cancer Predictive Genetic Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Brea…